Close

Not a member yet? Register now and get started.

lock and key

Sign in to your account.

Account Login

Forgot your password?

Healthcare  // Browsing posts in Healthcare

Camurus and Indivior Set to Significantly Sway the Opioid Abuse Treatment Market (INDV)

Research Question: How will the new long-acting buprenorphine options and changing government rules affect the opioid abuse treatment market? Companies: ALKS, DEPO, LON:INDV, STO:CAMX, STO:ORX, TTNP By: David Franklin Click here to download report (.pdf)   Summary of Findings Weekly and monthly injectable buprenorphine treatments that could significantly affect the medication-assisted treatment (MAT) market for […]

Read more...

Buprenorphine Idea Proposal (INDV)

Buprenorphine Idea Proposal (INDV)

How will the new long-acting buprenorphine treatment option and changing government rules affect the opioid treatment market? Report Available:March 2, 2017   Blueshift’s initial research found the opioid dependence treatment market on the verge of a major disruption. Due to the opioid addiction epidemic, government rules and regulations are allowing physicians to expand the number […]

Read more...

ICD and CRT Premature Battery Depletion Idea Proposal (MDT, STJ)

ICD and CRT Premature Battery Depletion Idea Proposal (MDT, STJ)

Are manufacturers of ICDs and CRTs at risk for major product recalls due to Premature Battery Depletion? Report Available: March 15, 2017   Blueshift’s initial research, in conjunction with Pharm3r software solutions, reveals a pattern of Premature Battery Depletion for several ICD and CRT devices that is consistent with other ICDs and CRTs that have […]

Read more...

Steady Growth Trend Continues for the Dental Market (XRAY)

Research Question: What are the current dental industry market conditions? Companies: ALGN, HSIC, PDCO, WEB, XRAY By: David Franklin Click here to download report (.pdf)   Summary of Findings In a follow-up to Blueshift Research’s 15 report on Dentsply Sirona Inc. (XRAY), dental market conditions continue to fluctuate, but they have improved for all five […]

Read more...

Steady Adoption Growth Expected for Dentsply Sirona’s CEREC (XRAY)

Research Question: Will Dentsply Sirona’s merger lead to accelerated adoption of its CEREC CAD/CAM system? Companies: ALGN, HPE, HSIC, MMM, PDCO, XRAY By: David Franklin Click here to download report (.pdf)   Summary of Findings Dentsply Sirona Inc. (XRAY) will see steady growth in the adoption of its CEREC system, according to 14 of 18 dentists, […]

Read more...

HEDIS Will Create Modest Growth for Exact Sciences’ Cologuard (EXAS)

Research Question: Will the inclusion of Cologuard in the 2017 HEDIS quality measures drive growth for Exact Sciences? Companies: DGX, EPGNF, EXAS, GE, LH, SIEGY, TYO:6502 By: David Franklin Click here to download report (.pdf)   Summary of Findings The inclusion and equal footing of Exact Sciences Corp.’s (EXAS) Cologuard in the 2017 Healthcare Effectiveness Data […]

Read more...

Dentsply Sirona Idea Proposal

Dentsply Sirona Idea Proposal

Will the Dentsply Sirona merger lead to accelerated adoption of its CEREC CAD/CAM system? Report Available: September 15, 2016   Blueshift’s initial research found Dentsply’s recently completed merger with Sirona creating an opportunity for increased adoption of the CEREC system and a continued shift to digital dentistry and single-visit dentistry. However, film X-rays are still […]

Read more...

Exact Sciences Idea Proposal (EXAS)

Exact Sciences Idea Proposal (EXAS)

Will the inclusion of Cologuard in the 2017 HEDIS quality measures drive growth for Exact Sciences? Report Available:August 31, 2016   Blueshift’s initial research shows that momentum for Cologuard, EXAS’s colon cancer screening test, has picked up recently as a governing body clarified language that the test is on equal standing among other screening tests, […]

Read more...

Jun 24 2016 Biotechnology, Healthcare

NVDQ’s DermACELL On Track to Achieve 2016 Sales Goal of $10 Million

Research Question: Will Novadaq grow DermACELL sales to $10 million in 2016 and $50 million or more by 2018? Companies: AGN, IART, JNJ, MDXG, NVDQ, NVS, OSIR By: David Franklin Click here to download the report (.pdf)   Summary of Findings DermACELL, an acellular dermal matrix (ADM) tissue that is used primarily in breast reconstruction, is likely […]

Read more...

Perrigo Recovery Will Happen, Expected to Take Time

Research Question: Will Perrigo recover from a recent string of negative developments to see growth over the short and long term in its three main business lines? Companies: GSK, JNJ, MYL, PRGO, TEVA By: David Franklin Click here to download the report (.pdf)   Summary of Findings Perrigo Co. plc (PRGO) is expected to recover over time […]

Read more...